Idorsia Ltd (SWX:IDIA)
Switzerland
· Delayed Price · Currency is CHF 6.86
+0.84 (13.95%)
Jun 26, 2026, 5:30 PM CET
Idorsia Employees
As of December 31, 2025, Idorsia had 487 total employees, including 424 full-time and 63 part-time employees. The number of employees decreased by 163 or -25.08% compared to the previous year.
Employees
487
Change
-163
Growth
-25.08%
Revenue / Employee
480.47K CHF
Profits / Employee
-483.57K CHF
Market Cap
1.75B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 487 | -163 | -25.08% |
| Dec 31, 2017 | 650 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Basilea Pharmaceutica AG | 189 |
| Bachem Holding AG | 2,595 |
| Newron Pharmaceuticals | 27 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 33 |
| Molecular Partners AG | 134 |
| Xlife Sciences AG | 20 |
| Addex Therapeutics | 3 |
Idorsia News
- 5 days ago - Idorsia price target raised to CHF 4.50 from CHF 4 at Deutsche Bank - TheFly
- 19 days ago - Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon - GlobeNewsWire
- 27 days ago - Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology - GlobeNewsWire
- 27 days ago - New analysis of Idorsia's aprocitentan demonstrates significant and sustained reduction in albuminuria in patients with uncontrolled / resistant hypertension - GlobeNewsWire
- 7 weeks ago - Shareholders vote in favor of all proposals by the Board at Idorsia's Annual General Meeting 2026 - GlobeNewsWire
- 2 months ago - Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year - GlobeNewsWire
- 2 months ago - Idorsia Quarterly report: Q1 2026 - Filings
- 2 months ago - Idorsia Earnings release: Q1 2026 - Filings